FeaturedNeurosciencePsychology·April 18, 2025·5 min readPotential Depression Risk Linked to Ozempic-Like DrugsA new international study reveals a possible connection between GLP1 receptor agonists—used in drugs like Ozempic—and increased risk of depression and suicidal ideation, especially in people with low dopamine function. Researchers used advanced pharmacogenomic tools to identify genetic pathways that may be vulnerable to dopamine dysregulation when exposed to these medications.Read More
FeaturedNeurologyNeuroscience·April 9, 2024·6 min readCannabis Use Linked to Lower Dementia RiskRecreational cannabis use may be associated with a significant decrease in the odds of experiencing subjective cognitive decline (SCD) in adults over 45. Analyzing data from the CDC's 2021 Behavioral Risk Factor Surveillance System, researchers found that recreational users had 96% lower odds of reporting SCD compared to non-users.Read More
FeaturedNeuroscience·April 4, 2023·1 min readAffective Computing: Computers Have Feelings TooResearchers turn to affective computing, a branch of artificial intelligence that promotes emotional intelligence in algorithms, to recognize, process, interpret, and simulate human empathy.Read More
FeaturedNeurologyNeuroscience·April 25, 2022·6 min readCould Pulsed Electronically Generated Electromagnetic Fields Cause Alzheimer’s?Pulsed electronically generated electromagnetic fields (EMFs) used for wireless communications produce electric and magnetic forces that act in the body's cells by activating voltage-gated calcium channels (VGCCs). VGCC activation induces changes that increase intracellular calcium levels. Researchers link EMF exposure to changes that lead to excessive intracellular calcium. This could have implications for the development of Alzheimer's disease.Read More
FeaturedNeuroscience·May 19, 2017·3 min readStressing the Brain Through Technology May Reduce Age Related DiseasesA new study describes how advances in technology can help us avoid aging and age related diseases.Read More